Benayed #NGDx18 Shows interesting cases - a BCR-NTRK2 fusion, in exon 16 (not targeted in DNA). Another - 10% tumor… https://t.co/JS9pKxL0oA

4:49pm August 22nd 2018 via Twitter Web Client